Study Stopped
No interested parties agreed to enroll. Poor enrolling rate. In March 2018, the study was terminated.
Atrial Fibrillation Registry in Jordan
JoAFR
1 other identifier
observational
2,000
1 country
1
Brief Summary
Prospective registry of all new comers with Atrial fibrillation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 8, 2016
CompletedFirst Posted
Study publicly available on registry
February 11, 2016
CompletedStudy Start
First participant enrolled
August 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedMay 25, 2023
May 1, 2023
1 year
February 8, 2016
May 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of stroke and systemic embolization and cardiovascular death
all ischemic and hemorrhagic strokes and embolization to any arterial bed during follow up period
1 year
Secondary Outcomes (2)
Number of readmission for atrial fibrillation
1 year
Number of readmission for other cardiovascular events
1 year
Study Arms (1)
AF cohort
AF consecutive patients
Eligibility Criteria
All new admissions with atrial fibrillation above the age of 18 or those who develop atrial fibrillation during hospitalization for non AF reason.
You may qualify if:
- Admission with atrial fibrillation
- developing atrial fibrillation during hospitalization for mon AF reason.
- age 18 or more years.
- patients welling to participate in the registry.
You may not qualify if:
- age less than 18 years.
- patients not welling to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istishari hospital
Amman, 11954, Jordan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Munir Zaqqa, MD FACC
Istishari Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co- investigator with Munir Zaqqa, MD, FACC
Study Record Dates
First Submitted
February 8, 2016
First Posted
February 11, 2016
Study Start
August 1, 2016
Primary Completion
August 1, 2017
Study Completion
March 1, 2018
Last Updated
May 25, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share